IDEXX Laboratories EBITDA Margin 2010-2024 | IDXX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for IDEXX Laboratories (IDXX) over the last 10 years. The current EBITDA margin for IDEXX Laboratories as of March 31, 2024 is .
| IDEXX Laboratories EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-03-31 | $3.73B | $1.23B | 33.06% |
| 2023-12-31 | $3.66B | $1.21B | 33.10% |
| 2023-09-30 | $3.59B | $1.19B | 33.21% |
| 2023-06-30 | $3.52B | $1.16B | 33.03% |
| 2023-03-31 | $3.43B | $1.04B | 30.42% |
| 2022-12-31 | $3.37B | $1.01B | 29.98% |
| 2022-09-30 | $3.34B | $0.98B | 29.39% |
| 2022-06-30 | $3.31B | $0.96B | 29.04% |
| 2022-03-31 | $3.27B | $1.04B | 31.73% |
| 2021-12-31 | $3.22B | $1.04B | 32.26% |
| 2021-09-30 | $3.14B | $1.02B | 32.54% |
| 2021-06-30 | $3.05B | $0.97B | 31.67% |
| 2021-03-31 | $2.86B | $0.90B | 31.37% |
| 2020-12-31 | $2.71B | $0.79B | 29.26% |
| 2020-09-30 | $2.59B | $0.72B | 27.79% |
| 2020-06-30 | $2.47B | $0.69B | 27.69% |
| 2020-03-31 | $2.46B | $0.65B | 26.63% |
| 2019-12-31 | $2.41B | $0.64B | 26.60% |
| 2019-09-30 | $2.35B | $0.64B | 27.15% |
| 2019-06-30 | $2.29B | $0.61B | 26.81% |
| 2019-03-31 | $2.25B | $0.59B | 26.39% |
| 2018-12-31 | $2.21B | $0.57B | 25.94% |
| 2018-09-30 | $2.17B | $0.56B | 25.67% |
| 2018-06-30 | $2.12B | $0.54B | 25.51% |
| 2018-03-31 | $2.05B | $0.52B | 25.28% |
| 2017-12-31 | $1.97B | $0.50B | 25.19% |
| 2017-09-30 | $1.91B | $0.48B | 25.29% |
| 2017-06-30 | $1.86B | $0.47B | 25.19% |
| 2017-03-31 | $1.82B | $0.45B | 24.73% |
| 2016-12-31 | $1.78B | $0.43B | 24.16% |
| 2016-09-30 | $1.73B | $0.41B | 23.60% |
| 2016-06-30 | $1.69B | $0.39B | 23.18% |
| 2016-03-31 | $1.64B | $0.37B | 22.79% |
| 2015-12-31 | $1.60B | $0.37B | 23.11% |
| 2015-09-30 | $1.55B | $0.34B | 21.57% |
| 2015-06-30 | $1.53B | $0.33B | 21.69% |
| 2015-03-31 | $1.51B | $0.33B | 21.55% |
| 2014-12-31 | $1.49B | $0.32B | 21.47% |
| 2014-09-30 | $1.49B | $0.34B | 23.12% |
| 2014-06-30 | $1.44B | $0.34B | 23.23% |
| 2014-03-31 | $1.41B | $0.33B | 23.49% |
| 2013-12-31 | $1.38B | $0.32B | 23.38% |
| 2013-09-30 | $1.34B | $0.32B | 24.13% |
| 2013-06-30 | $1.32B | $0.32B | 24.32% |
| 2013-03-31 | $1.30B | $0.32B | 24.33% |
| 2012-12-31 | $1.29B | $0.32B | 24.34% |
| 2012-09-30 | $1.28B | $0.31B | 23.89% |
| 2012-06-30 | $1.27B | $0.30B | 23.52% |
| 2012-03-31 | $1.25B | $0.29B | 23.38% |
| 2011-12-31 | $1.22B | $0.28B | 23.30% |
| 2011-09-30 | $1.20B | $0.28B | 23.33% |
| 2011-06-30 | $1.17B | $0.27B | 23.35% |
| 2011-03-31 | $1.13B | $0.26B | 22.61% |
| 2010-12-31 | $1.10B | $0.25B | 22.64% |
| 2010-09-30 | $1.09B | $0.24B | 22.39% |
| 2010-06-30 | $1.08B | $0.24B | 22.24% |
| 2010-03-31 | $1.06B | $0.24B | 22.09% |
| 2009-12-31 | $1.03B | $0.23B | 21.92% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $39.691B | $3.661B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributer of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.485B | 26.48 |
| Intuitive Surgical (ISRG) | United States | $135.271B | 81.49 |
| Edwards Lifesciences (EW) | United States | $51.372B | 33.43 |
| DexCom (DXCM) | United States | $51.051B | 77.33 |
| IQVIA Holdings (IQV) | United States | $40.698B | 23.61 |
| Alcon (ALC) | Switzerland | $39.236B | 28.93 |
| STERIS (STE) | Ireland | $20.536B | 24.31 |
| Waters (WAT) | United States | $19.053B | 27.34 |
| Hologic (HOLX) | United States | $17.966B | 19.98 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.387B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.392B | 85.37 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.306B | 15.20 |
| Sysmex ADR (SSMXY) | Japan | $10.920B | 34.24 |
| Teleflex (TFX) | United States | $9.562B | 14.88 |
| Penumbra (PEN) | United States | $8.083B | 99.79 |
| Masimo (MASI) | United States | $7.249B | 40.65 |
| Globus Medical (GMED) | United States | $7.033B | 22.30 |
| Glaukos (GKOS) | United States | $5.346B | 0.00 |
| TransMedics (TMDX) | United States | $4.216B | 399.97 |
| Integer Holdings (ITGR) | United States | $3.728B | 22.52 |
| LivaNova (LIVN) | United Kingdom | $3.474B | 20.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.307B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.888B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.712B | 18.60 |
| Nihon Kohden (NHNKY) | Japan | $2.490B | 21.06 |
| Inari Medical (NARI) | United States | $2.444B | 0.00 |
| RxSight (RXST) | United States | $2.281B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.271B | 9.32 |
| Alphatec Holdings (ATEC) | United States | $1.908B | 0.00 |
| Veracyte (VCYT) | United States | $1.556B | 0.00 |
| OPKO Health (OPK) | United States | $0.906B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.903B | 17.57 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| Artivion (AORT) | United States | $0.862B | 99.67 |
| Silk Road Medical (SILK) | United States | $0.800B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.781B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.679B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.623B | 21.15 |
| SiBone (SIBN) | United States | $0.585B | 0.00 |
| IRadimed (IRMD) | United States | $0.566B | 31.70 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.509B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.498B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.432B | 0.00 |
| Nevro (NVRO) | United States | $0.414B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.339B | 11.42 |
| Sight Sciences (SGHT) | United States | $0.295B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| AxoGen (AXGN) | United States | $0.253B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.199B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.23 |
| 908 Devices (MASS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| Accuray (ARAY) | United States | $0.161B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.159B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.154B | 0.00 |
| Neuronetics (STIM) | United States | $0.114B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.106B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.085B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.061B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.060B | 121.67 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| InspireMD (NSPR) | Israel | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| PAVmed (PAVM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |